Picture of Vascular & Interventional Centre

Vascular & Interventional Centre

The Vascular & Interventional Centre (VIC), located in Singapore, is gaining recognition for its approach to vascular surgery. It offers minimally invasive procedures that allow 80% of patients to be discharged on the same day. This model challenges traditional methods, often requiring prolonged hospital stays, offering a more efficient, patient-focused alternative. VIC specializes in treating vascular conditions without needing full hospital admissions, significantly benefiting patients in terms of convenience and recovery time.

Vascular

The Vascular & Interventional Centre (VIC), located in Singapore, is gaining recognition for its approach to vascular surgery. It offers minimally invasive procedures that allow 80% of patients to be discharged on the same day. This model challenges traditional methods, often requiring prolonged hospital stays, offering a more efficient, patient-focused alternative. VIC specializes in treating vascular conditions without needing full hospital admissions, significantly benefiting patients in terms of convenience and recovery time.


Founded in 2015 by Dr. Benjamin Chua, the centre offers a wide range of services using advanced imaging and surgical techniques. The emphasis on day surgeries aligns with global healthcare trends prioritizing outpatient care to reduce healthcare costs and improve efficiency. VIC is one of the few specialized clinics in Southeast Asia with a dedicated hybrid operating theatre, integrating cutting-edge technology to enhance patient outcomes.


The clinic’s ability to offer complex procedures without requiring overnight stays positions it as a leader in outpatient vascular care, setting it apart from larger institutions that traditionally rely on extended hospital stays for similar treatments.

Patient-Centric Care and Technological Innovation

VIC places a strong emphasis on tailoring treatments to the individual needs of each patient. The centre uses advanced Philips Fluoroscopy Systems to provide precise diagnostics and minimize invasive surgical methods, contributing to shorter recovery periods. The hybrid operating theatre allows doctors to perform complex interventions with more precision, leading to better patient outcomes.


“We aim to provide world-class vascular care that maximizes patient comfort and minimizes disruption to their daily lives,” said Dr. Chen Min Qi, who joined VIC in 2023. The clinic’s commitment to technological innovation allows for comprehensive treatment options across various vascular conditions, including deep vein thrombosis, varicose veins, and even cancer-related interventions.


VIC’s model, focusing on efficiency and patient well-being, reflects the broader trend in healthcare towards outpatient care and minimally invasive procedures. This ensures a better quality of life for patients and addresses the growing need for cost-effective solutions in healthcare.
Vascular2

Industry Impacts and Competitive Positioning

Vascular L

The healthcare industry is seeing increased demand for cost-effective outpatient solutions, especially for chronic conditions like diabetes, which frequently require vascular interventions. VIC’s focus on day surgeries could influence other healthcare providers to adopt similar models, making high-quality, minimally invasive care more accessible.


As larger hospitals, such as Singapore General Hospital (SGH), offer a broad range of services, VIC’s specialization allows it to stand out. Its highly specialized focus on vascular health and advanced technology for day surgeries give VIC a competitive edge. The clinic’s leadership, notably Dr. Chua’s expertise in the field of vascular surgery, also adds credibility and positions the centre as a key player in Singapore’s healthcare ecosystem.


While other clinics and hospitals may offer similar services, VIC’s approach demonstrates that high-quality care can be delivered more efficiently, which may encourage shifts in industry standards.

Future Prospects in Outpatient Healthcare

VIC is well-positioned to expand its impact across Southeast Asia. The demand for outpatient and minimally invasive treatments is expected to grow as healthcare systems seek to reduce costs and improve patient experiences globally. VIC’s partnership with Philips and its continual investment in the latest technologies will likely enable it to remain at the forefront of vascular healthcare innovation.


“We’re just beginning,” Dr. Chua emphasized, adding that he sees significant potential in expanding the clinic’s day surgery model regionally. By consistently improving patient outcomes and reducing recovery times, VIC is a pioneer in transforming how healthcare is delivered, particularly in vascular health.


The clinic’s focus on innovation, efficiency, and patient care suggests that its model could be adopted more widely, marking a significant shift in how complex surgeries are handled in outpatient settings.
Vascular Ld